Cancer cell viability vs normal HEK293T cells

The term 'Cancer cell viability vs normal HEK293T cells' does not refer to a specific molecular target, receptor, or enzyme. Instead, it describes a phenotypic screening assay or a comparative metric used in pharmacology and oncology research to evaluate the selective toxicity of a compound. In this context, researchers measure the ability of a drug candidate to kill cancer cells while sparing HEK293T cells, which are a commonly used 'normal' or non-cancerous human embryonic kidney cell line (Source: ATCC). This comparison is critical for determining the therapeutic index and potential safety profile of a drug, as high selectivity for cancer cells over HEK293T cells suggests a lower risk of general systemic toxicity (Source: NIH, Assay Guidance Manual). Because this is an experimental observation or assay methodology rather than a biological entity, it cannot be classified under standard molecular or therapeutic target categories.